SUPN
Supernus Pharmaceuticals Inc
43.80$
+2.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.41 | 2.82 | 4.16 | 5.67 | 7.56 | 7.30 | 9.69 | 10.67 | 10.82 | 10.94 | 11.83 | 12.74 | |
| 0.11 | 0.16 | 0.23 | 0.29 | 0.28 | 0.31 | 0.98 | 1.38 | 1.41 | 1.51 | 1.39 | 1.32 | |
| 2.30 | 2.66 | 3.93 | 5.38 | 7.27 | 6.99 | 8.72 | 9.29 | 9.40 | 9.44 | 10.43 | 11.42 | |
| 0.39 | 0.57 | 0.83 | 0.93 | 1.65 | 1.28 | 1.41 | 1.66 | 1.21 | 1.65 | 1.94 | 1.88 | |
| 1.14 | 1.37 | 1.63 | 1.95 | 2.16 | 2.19 | 1.23 | 1.93 | 1.77 | 4.26 | 4.42 | 3.49 | |
| 1.82 | 2.31 | 2.88 | 3.52 | 4.60 | 4.23 | 5.48 | 7.70 | 8.66 | 9.53 | 8.98 | 12.07 | |
| 0.48 | 0.35 | 1.05 | 1.87 | 2.67 | 2.76 | 3.24 | 1.58 | 0.75 | -0.09 | 1.46 | -0.65 | |
| 0.11 | 0.09 | 0.10 | 0.03 | 0.33 | 0.42 | 0.44 | 0.43 | 0.11 | 0.04 | 0.00 | 0.00 | |
| 0.39 | 0.29 | 0.97 | 1.89 | 2.59 | 2.74 | 3.14 | 1.35 | 0.98 | 0.05 | 1.75 | -0.87 | |
| 0.08 | 0.02 | -0.79 | 0.81 | 0.54 | 0.64 | 0.78 | 0.36 | 0.00 | 0.03 | 0.43 | -0.19 | |
| 0.39 | 0.27 | 1.76 | 1.07 | 2.05 | 2.10 | 2.36 | 0.98 | 0.98 | 0.02 | 1.32 | -0.68 | |
| -0.09 | 0.43 | 1.09 | 2.02 | 2.80 | 3.35 | 3.92 | 2.38 | 2.49 | 1.62 | 3.19 | 0.75 |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.